arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Enanta Pharmaceuticals, Inc.

ENTA Health Care Biotechnology: Pharmaceutical Preparations
$11.64
▲ +2.9% Today
as of Oct 23, 16:48 ET
Last 30 days -11.28% Sep 14 → Oct 23
$10.93 $11.54 $12.14 $12.74 $13.35 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$11.57
High
$11.67
Low
$10.97
Volume
$228,230
Avg Vol
$241,833
Mkt Cap
$382M
P/E (TTM)
—
Beta
—
52w High
$17.15
52w Low
$10.22
Div Yield
—
Shares Out
$29M

Recent Press Releases & News last 60 days · 2 items

Oct 13 · 11:00 PR Business Wire
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at IDWeek™ 2026
Sep 1 · 11:00 PR Business Wire
Enanta Pharmaceuticals to Participate in September Investor Conferences

ENTA earnings at a glance

The options market is pricing a move of about ±18.2% after the report, a range of roughly $9.52 to $13.76 from today's $11.64. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±3.0% on average; after the most recent report on May 11, 2026 it moved +0.8%. That means options currently expect more movement than ENTA has typically delivered. ENTA beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 109%. The share price of $11.64 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$10
$17
20% of range
Avg surprise (last 3)
+10.8%
Avg reaction (last 2)
+3.0%
100% positive
Latest IV / EM
109%
EM ±18.2% · $13 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.86$-1.50$-1.14$-0.78$-0.42 Actual $-1.79Actual $-1.86Actual $-1.58Actual $-1.47Actual $-1.07Actual $-1.05Actual $-1.06Est $-1.04Actual $-0.85Est $-1.25Actual $-0.42Actual $-0.45Est $-0.46Actual $-0.67 MarJunDecMarJunDecMar/2025Jun/2025DecMar/2026Jun
Revenue vs Net Income Revenue Net income
$-23M$-12M$-2M$9M$20M Dec 24Mar 25Jun 25Dec 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.67 — — — — financials
Mon May 11, 2026Mar/2026 $-0.45 $-0.46 +2.2% +57.5% +0.8% earnings
Wed Dec 31, 2025Dec 2025 $-0.42 — — — — financials
Mon Aug 11, 2025Jun/2025 $-0.85 $-1.25 +32.0% — — earnings
Mon May 12, 2025Mar/2025 $-1.06 $-1.04 -1.9% — +5.3% earnings
Tue Dec 31, 2024Dec 2024 $-1.05 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.07 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.47 — — — — financials
Sun Dec 31, 2023Dec 2023 $-1.58 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.86 — — — — financials
Fri Mar 31, 2023Mar 2023 $-1.79 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$14M$17M$19M—$18M$15M$17M—
Cost of revenue————————
Gross profit————————
Operating income$-17M$-12M$-11M—$-19M$-25M$-24M—
Net income$-20M$-13M$-12M—$-18M$-23M$-22M—
EPS (diluted)$-0.67$-0.45$-0.42—$-0.85$-1.06$-1.05—

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$33M$35M$37M$32M$45M$60M$84M$37M
Inventory————————
Total current assets$204M$178M$199M$204M$223M$243M$268M$300M
Total assets$297M$315M$330M$281M$301M$323M$349M$377M
Long-term debt————————
Total liabilities$196M$198M$203M$216M$222M$229M$237M$248M
Total equity$101M$117M$127M$65M$79M$94M$112M$129M

Implied volatility — last 90 days

15%74%133%192%251% Jun 09 — IV 239% · EM ±30.0%Jun 11 — IV 252% · EM ±27.8%Jun 19 — IV 116% · EM ±25.7%Jun 22 — IV 107% · EM ±22.4%Jun 23 — IV 96% · EM ±19.6%Jun 24 — IV 98% · EM ±19.7%Jun 25 — IV 110% · EM ±21.6%Jun 26 — IV 80% · EM ±15.2%Jun 30 — IV 74% · EM ±12.7%Jul 01 — IV 64% · EM ±10.7%Jul 02 — IV 74% · EM ±11.9%Jul 03 — IV 76% · EM ±11.9%Jul 07 — IV 21% · EM ±2.8%Jul 20 — IV 84% · EM ±19.9%Jul 21 — IV 29% · EM ±6.7%Jul 22 — IV 84% · EM ±19.1%Jul 23 — IV 43% · EM ±9.7%Jul 24 — IV 78% · EM ±17.2%Jul 27 — IV 41% · EM ±8.6%Jul 28 — IV 92% · EM ±18.8%Jul 29 — IV 88% · EM ±17.7%Jul 30 — IV 49% · EM ±9.6%Jul 31 — IV 60% · EM ±11.5%Aug 03 — IV 59% · EM ±10.4%Aug 04 — IV 48% · EM ±8.3%Aug 05 — IV 102% · EM ±17.0%Aug 06 — IV 171% · EM ±27.7%Aug 07 — IV 184% · EM ±28.7%Aug 17 — IV 205% · EM ±17.1%Aug 19 — IV 194% · EM ±11.5%Aug 20 — IV 246% · EM ±10.3%Aug 24 — IV 67% · EM ±14.0%Aug 25 — IV 71% · EM ±14.6%Aug 26 — IV 48% · EM ±9.5%Aug 28 — IV 15% · EM ±2.9%Aug 31 — IV 21% · EM ±3.8%Sep 01 — IV 148% · EM ±25.5%Sep 02 — IV 51% · EM ±8.5%Sep 08 — IV 22% · EM ±3.0%Sep 09 — IV 24% · EM ±3.0%Sep 10 — IV 47% · EM ±5.5%Sep 11 — IV 38% · EM ±4.2%Sep 14 — IV 50% · EM ±4.2%Sep 15 — IV 90% · EM ±6.5%Sep 16 — IV 107% · EM ±6.3%Sep 21 — IV 83% · EM ±17.3%Sep 22 — IV 51% · EM ±10.5%Sep 23 — IV 110% · EM ±22.0%Sep 25 — IV 108% · EM ±20.6%Sep 28 — IV 116% · EM ±20.6%Sep 29 — IV 106% · EM ±18.2%Sep 30 — IV 109% · EM ±18.2%

Sector peers

RLMD
Relmada Therapeutics, Inc.
$390M $3.27+1.9%
TTRX
Turn Therapeutics Inc.
$396M $10.28+1.3%
EBS
Emergent BioSolutions Inc.
$363M $6.23+0.5%
BNTC
Benitec Biopharma Inc.
$334M $8.65+1.8%
DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%
PRLD
Prelude Therapeutics Incorporated
$302M $3.63-0.6%

ENTA earnings FAQ

What is ENTA's expected move for earnings?

Options currently price a move of about ±18.2%, or $2.12 per share either way from $11.64.

How does ENTA stock usually react to earnings?

Across the last 2 reports the average next-day move was ±3.0%, up 2 times and down 0 times.

What is ENTA's implied volatility?

ENTA's at-the-money implied volatility is about 109% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in